BTTAA-OH
BTTAA-OH is a kind of tris (triazolylmethyl) amine compound. BTTAA-OH has the potential for the research of labeling and/or imaging in living system (extracted from patent WO2012021390A1) [1].
Product Specifications
CAS Number
[1257633-69-4]
UNSPSC
12352005
Hazard Statement
H228, H315, H319
Target
Biochemical Assay Reagents
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/bttaa-oh.html
Purity
99.14
Solubility
H2O : 12.5 mg/mL (ultrasonic)
Smiles
OCCN1N=NC(CN(CC2=CN(C(C)(C)C)N=N2)CC3=CN(C(C)(C)C)N=N3)=C1
Molecular Formula
C19H32N10O
Molecular Weight
416.52
Precautions
H228, H315, H319
References & Citations
[1]Peng Wu, et al. Ligands and methods for labeling biomolecules in vivo. Patent WO2012021390A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Human Monoclonal APRIL/TNFSF13 Antibody (sibeprenlimab) [Janelia Fluor 669]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-28614JF669 0.1 mL
Human Monoclonal APRIL/TNFSF13 Antibody (sibeprenlimab) [Janelia Fluor 669]
Sign In for Pricing
View Details abx149161-01 50 µg
CDK5 Regulatory Subunit Associated Protein 1 (CDK5RAP1) Antibody
Sign In for Pricing
View Details 
abx149161-02 100 µg
CDK5 Regulatory Subunit Associated Protein 1 (CDK5RAP1) Antibody
Sign In for Pricing
View Details 